• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    1/23/23 1:44:32 PM ET
    $ALLR
    $AMRS
    $AMST
    $ANPC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Chemicals
    Industrials
    Get the next $ALLR alert in real time by email

    Gainers

    • Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
    • Verb Technology Company, Inc. (NASDAQ:VERB) surged 83.4% to $0.4195 after the company announced its board of directors has begun examining measures to address the alleged illegal short selling of its stock, among other suspected trading violations.
    • Pliant Therapeutics, Inc.. (NASDAQ:PLRX) shares jumped 58% to $35.56 after the company announced its trial for patients with Idiopathic Pulmonary Fibrosis met its primary and secondary endpoints.
    • Boxed, Inc. (NYSE:BOXD) shares rose 41.7% to $0.6699 after the company reported up to $20 million of new financing.
    • Helbiz, Inc. (NASDAQ:HLBZ) rose 36.2% to $0.2776. Helbiz shares jumped 65% on Friday after the company said its Board of Directors has begun examining measures to address alleged illegal short selling of its stock.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) surged 28% to $0.6563.
    • Theriva Biologics, Inc. (NYSE:TOVX) jumped 26.9% to $0.9698.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) gained 23.5% to $0.4280.
    • Wayfair Inc. (NYSE:W) gained 23.5% to $57.78 after multiple analysts upgraded the stock in the wake of the company's cost efficiency plan and business performance update.
    • SciSparc Ltd. (NASDAQ:SPRC) surged 20% to $1.01. SciSparc will investigate concerns of 'illegal trading of ordinary shares.'
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 20% to $0.3046 after gaining over 16% on Friday. Allarity Therapeutics announced adjournment of 2023 annual meeting of stockholders.
    • Vaxxinity, Inc. (NASDAQ:VAXX) jumped 19.8% to $3.59.
    • Digihost Technology Inc. (NASDAQ:DGHI) surged 19.4% to $1.23.
    • T Stamp Inc. (NASDAQ:IDAI) surged 17.1% to $0.76. Trust Stamp received notice of allowance from the U.S. Patent and Trademark Office.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) jumped 16% to $2.9799.
    • Freeline Therapeutics Holdings plc (NASDAQ:FRLN) gained 15.9% to $0.6375.
    • Paltalk, Inc. (NASDAQ:PALT) surged 15.4% to $2.99.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) shares rose 13.6% to $2.9185. DBG recently announced closing of $5.0 million private placement priced at-the-market under Nasdaq rules.
    • Amyris, Inc. (NASDAQ:AMRS) gained 12.7% to $1.77.
    • Argo Blockchain plc (NASDAQ:ARBK) gained 12.4% to $1.9450.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) jumped 12.6% to $18.19.
    • XPeng Inc. (NYSE:XPEV) surged 11.8% to $10.52.
    • Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) shares gained 12% to $4.64. Cadrenal Therapeutics was granted FDA Fast Track designation for tecarfarin for prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) surged 12.2% to $0.6880. Faraday Future recently announced a strategic agreement with the city of Huanggang in Hubei Province, China and signed a new shareholder agreement with FF Global Partners LLC.
    • NIO Inc. (NYSE:NIO) surged 10.5% to $12.24.
    • Evoqua Water Technologies Corp. (NASDAQ:AQUA) gained 10.3% to $45.27 after Xylem announced it will acquire the company in a $7.5 billion all-stock transaction.
    • Lucid Group, Inc. (NASDAQ:LCID) gained 10.3% to $8.62. Lucid Group has taken down prices of its pricier electric vehicle sedan, but the price incentive is not available for all buyers, a report said on Friday.
    • Genius Group Limited (NYSE:GNS) shares rose 10.2% to $3.59. Genius Group shares jumped 55% on Friday on continued strength after the company approved a plan to create an 'Illegal Trading Task Force.'
    • Opendoor Technologies Inc. (NASDAQ:OPEN) gained 9.6% to $1.7550.
    • Nikola Corporation (NASDAQ:NKLA) jumped 7.9% to $2.72. GP JOULE announced plans to order 100 Nikola Tre Fuel Cell Electric Vehicles.
    • Western Digital Corporation (NASDAQ:WDC) gained 6.7% to $41.04 following a media report that the company is in merger talks with Japan's Kioxia Holdings.
    • Salesforce, Inc. (NYSE:CRM) gained 3% to $155.68. Activist investor Elliott Management Corp has reportedly picked up a multi-billion dollar stake in cloud software firm Salesforce, the Wall Street Journal reported, citing people familiar with the matter.

    Losers

    • Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) shares tumbled 29.9% to $14.59 after Teva Pharmaceuticals stated it plans to sell a generic version of Catalyst's FIRDAPSE in the United States.
    • Ryvyl Inc. (NASDAQ:RVYL) dropped 18.8% to $0.6636. RYVYL said it will 'continue to review past and present trades for potential violations, specifically with regards to regulation SHO.'
    • RenovoRx, Inc. (NASDAQ:RNXT) fell 17.2% to $2.69.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) fell 16.5% to $4.05.
    • VOC Energy Trust (NYSE:VOC) declined 16.2% to $10.96.
    • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) dropped 16.2% to $3.8050.
    • Eargo, Inc. (NASDAQ:EAR) fell 15.1% to $12.35 after jumping 26% on Friday. The company recently effected a 1:20 reverse stock split.
    • Nexalin Technology, Inc. (NYSE:NXL) declined 14.8% to $0.97.
    • Amesite Inc. (NASDAQ:AMST) dropped 14.4% to $0.2440.
    • Tailwind Acquisition Corp. (NYSE:TWND) fell 13.9% to $6.50.
    • Eve Holding, Inc. (NYSE:EVEX) fell 13.7% to $6.33. Eve Holding recently reported a third-quarter FY22 net loss of $(36.7) million versus a loss of $(3.8) million in 3Q21.
    • Jaguar Health, Inc. (NASDAQ:JAGX) fell 13.3% to $5.51. Jaguar Health announced establishment of board of directors for newly formed joint venture Magdalena Biosciences.
    • AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) dropped 12% to $8.48. AnPac Bio-Medical Sciences announced receipt of staff delisting determination from the Nasdaq.
    • Sientra, Inc. (NASDAQ:SIEN) fell 12.3% to $1.8050. Sientra announced a 1-for-10 reverse stock split.
    • Cosmos Health Inc. (NASDAQ:COSM) fell 10.3% to $4.78. Cosmos Health updated the payment terms of its agreement to acquire ZipDoctor.
    • Xylem Inc. (NYSE:XYL) dropped 9.5% to $99.70 after the company announced it would acquire Evoqua for $7.5B of Xylem stock.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) dropped 9.2% to $3.04. The company received a Nasdaq notice regarding a delayed quarterly report. It was also reported the company has hired a legal advisor ahead of a potential bankruptcy filing.
    • Ontrak, Inc. (NASDAQ:OTRK) fell 9.1% to $0.9639 after declining around 12% on Friday. Ontrak recently announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.

    Also Check This Out Crypto Market Cap Tops $1 Trillion; STEPN Emerges As Top Gainer

    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $AMRS
    $AMST
    $ANPC

    CompanyDatePrice TargetRatingAnalyst
    Wayfair Inc.
    $W
    2/20/2026$114.00 → $105.00Overweight
    Analyst
    Salesforce Inc.
    $CRM
    2/20/2026$275.00 → $235.00Outperform
    BMO Capital Markets
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$16.00Sell → Neutral
    UBS
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    Xylem Inc.
    $XYL
    1/26/2026Outperform
    William Blair
    More analyst ratings

    $ALLR
    $AMRS
    $AMST
    $ANPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst reiterated coverage on Wayfair with a new price target

    Analyst reiterated coverage of Wayfair with a rating of Overweight and set a new price target of $105.00 from $114.00 previously

    2/20/26 10:42:01 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    BMO Capital Markets reiterated coverage on Salesforce with a new price target

    BMO Capital Markets reiterated coverage of Salesforce with a rating of Outperform and set a new price target of $235.00 from $275.00 previously

    2/20/26 7:54:01 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Rivian Automotive downgraded by DA Davidson with a new price target

    DA Davidson downgraded Rivian Automotive from Neutral to Underperform and set a new price target of $14.00

    2/17/26 7:28:03 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $ALLR
    $AMRS
    $AMST
    $ANPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Tan Irving converted options into 32 shares and covered exercise/tax liability with 657 shares, decreasing direct ownership by 0.10% to 622,961 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/24/26 5:44:08 PM ET
    $WDC
    Electronic Components
    Technology

    Chief Legal Officer & Corp Sec Tregillis Cynthia L converted options into 12 shares, covered exercise/tax liability with 1,353 shares and sold $123,662 worth of shares (438 units at $282.33), decreasing direct ownership by 1% to 134,759 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/24/26 5:44:14 PM ET
    $WDC
    Electronic Components
    Technology

    Chief of Global Operations Gubbi Vidyadhara K converted options into 8 shares and covered exercise/tax liability with 920 shares, decreasing direct ownership by 0.72% to 125,952 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/24/26 5:43:58 PM ET
    $WDC
    Electronic Components
    Technology

    $ALLR
    $AMRS
    $AMST
    $ANPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lucid Files Resale Prospectus Supplement

    NEWARK, Calif., Feb. 24, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ:LCID), maker of the world's most advanced electric vehicles, today announced that it has filed a prospectus supplement with the Securities and Exchange Commission to register for resale up to 69,108,837 shares of its Class A Common Stock. No new shares will be issued or sold by Lucid in connection with this resale prospectus supplement. The shares were registered solely to fulfill Lucid's contractual obligations to (i) SMB Holding Corporation, a subsidiary of Uber Technologies, Inc., with respect to shares i

    2/24/26 4:06:00 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    Lucid Announces Fourth Quarter and Full Year 2025 Financial Results

    Financial HighlightsDelivered 5,345 vehicles in Q4 and 15,841 vehicles in 2025; up 72% compared to Q4 2024 and up 55% compared to full year 2024Nearly doubled production year over year and in-line with 2025 annual production guidance of approximately 18,000 vehicles despite supply chain and tariff headwindsQ4 2025 revenue of $522.7 million, up 123% compared to Q4 2024, and annual revenue of $1,353.8 million, up 68% compared to full year 2024GAAP diluted net loss per share of $(3.62) in Q4 2025 and $(12.09) in full year 2025Ended the quarter with approximately $4.6 billion in total liquidity2026 production guidance of 25,000-27,000 vehiclesOperational HighlightsAchieved an eighth consecutive

    2/24/26 4:05:00 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ALLR
    $AMRS
    $AMST
    $ANPC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ALLR
    $AMRS
    $AMST
    $ANPC
    SEC Filings

    View All

    SEC Form 10-K filed by Bed Bath & Beyond Inc.

    10-K - BED BATH & BEYOND, INC. (0001130713) (Filer)

    2/24/26 4:58:18 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Avalo Therapeutics Inc.

    SCHEDULE 13G - Avalo Therapeutics, Inc. (0001534120) (Subject)

    2/24/26 4:48:09 PM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lucid Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits

    8-K - Lucid Group, Inc. (0001811210) (Filer)

    2/24/26 4:21:23 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    $ALLR
    $AMRS
    $AMST
    $ANPC
    Financials

    Live finance-specific insights

    View All

    Lucid Announces Fourth Quarter and Full Year 2025 Financial Results

    Financial HighlightsDelivered 5,345 vehicles in Q4 and 15,841 vehicles in 2025; up 72% compared to Q4 2024 and up 55% compared to full year 2024Nearly doubled production year over year and in-line with 2025 annual production guidance of approximately 18,000 vehicles despite supply chain and tariff headwindsQ4 2025 revenue of $522.7 million, up 123% compared to Q4 2024, and annual revenue of $1,353.8 million, up 68% compared to full year 2024GAAP diluted net loss per share of $(3.62) in Q4 2025 and $(12.09) in full year 2025Ended the quarter with approximately $4.6 billion in total liquidity2026 production guidance of 25,000-27,000 vehiclesOperational HighlightsAchieved an eighth consecutive

    2/24/26 4:05:00 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    Bed Bath & Beyond, Inc. Reports Eighth Consecutive Quarter of Measurable Improvement Toward Profitability

    Q4 Reflects Strengthening Revenue Trends, Sustained Margin Expansion and a $118 Million Year-Over-Year Improvement in Operating Cash Flow Use Bed Bath & Beyond, Inc. (NYSE:BBBY), owner of Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland's Home and a blockchain asset portfolio, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company delivered its eighth consecutive quarter of measurable improvement toward profitability, reflecting continued margin expansion, disciplined cost management and consistent progress across key operating metrics. The Company has successfully built the base of its business through disciplined retail executio

    2/23/26 4:01:00 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Q4 2025 Open House: Opendoor 2.0 Does What It Said It Would Do — Delivering Acquisition Growth, Faster Inventory Turns, and Stronger Cohorts

    SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (NASDAQ:OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for its fourth quarter and year ended December 31, 2025. "Last quarter, we outlined a four-step plan to transform Opendoor: reach breakeven Adjusted Net Income by the end of 2026 on a 12-month go-forward basis, drive positive unit economics while increasing transaction velocity, transition to direct-to-consumer relationships, and expand our product suite. This quarter demonstrates we are executing on that plan," said Kaz Nejatian, CEO of Opendoor. "These results reflect structural improvements in

    2/19/26 4:05:00 PM ET
    $OPEN
    Real Estate
    Finance

    $ALLR
    $AMRS
    $AMST
    $ANPC
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Lucid Announces Appointment of Neil Marsons as Senior Vice President of Supply Chain

    NEWARK, Calif., Feb. 9, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ:LCID), maker of the world's most advanced electric vehicles, today announced Neil Marsons has joined the organization as the Senior Vice President of Supply Chain. Bringing more than 20 years of experience to the role, Marsons will be responsible for expanding and strengthening the company's global supply chain, as well as closely partnering across the organization to support production at the company's facilities in Arizona and Saudi Arabia. Previously, Marsons served as the Group Chief Procurement Officer

    2/9/26 10:49:00 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer

    MOUNTAIN VIEW, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, is pleased to announce the appointment of Mark Voll as the Company's Chief Financial Officer, effective February 1, 2026. Mr. Voll brings more than three decades of financial leadership experience to RenovoRx, with a strong track record for guiding high-growth public companies through periods of commercial buildout and strategic development. He has served as Chief Financial Officer for multiple publicly traded technology co

    2/5/26 8:30:00 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AMRS
    $AMST
    $ANPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Verb Technology Company Inc.

    SC 13G/A - Verb Technology Company, Inc. (0001566610) (Subject)

    11/15/24 8:24:57 PM ET
    $VERB
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by Pliant Therapeutics Inc.

    SC 13G - PLIANT THERAPEUTICS, INC. (0001746473) (Subject)

    11/14/24 9:00:58 PM ET
    $PLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Edible Garden AG Incorporated

    SC 13G/A - Edible Garden AG Inc (0001809750) (Subject)

    11/14/24 7:24:20 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples